Vecuronium Bromide Injection, Powder, Lyophilized, For Solution
Product Images NDC 55150-236

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Vecuronium Bromide (NDC 55150-236). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vecuronium-figure-1 (Vecuronium Fig1)

Vecuronium Bromide for Injection 10 mg per vial, lyophilized powder for intravenous use. The label includes warnings about its paralyzing effects and respiratory arrest risk. It states the product is sterile and provides directions for reconstitution with bacteriostatic or sterile water. Labeler is Eugia US LLC, with the barcode and NDC 55150-235-02 visible.*

FDA Label Image

Vecuronium-figure-2 (Vecuronium Fig2)

Packaging label for Vecuronium Bromide for Injection, 10 mg per vial, lyophilized powder for solution, for intravenous use. Label shows the warning of it being a paralyzing agent and indicates sterile, nonpyrogenic contents. Distributed by AuroMedics Pharma LLC and labeled with NDC 55150-235-11. The label includes preparation instructions to reconstitute to 10 mL and notes about vial stopper materials and storage conditions.*

FDA Label Image

Vecuronium-figure-3 (Vecuronium Fig3)

Vecuronium Bromide for Injection 20 mg per vial is a lyophilized powder for intravenous use. The label warns that the product is a paralyzing agent requiring immediate availability of artificial respiration facilities. Prepared solution concentration is 1 mg/mL when reconstituted to 20 mL. The product is sterile and intended for human prescription use, labeled by Eugia US LLC.*

FDA Label Image

Vecuronium-figure-4 (Vecuronium Fig4)

Packaging label for Vecuronium Bromide for Injection, lyophilized powder for solution, 20 mg per vial. The label highlights that this drug is a paralyzing agent for intravenous use only and is sterile and nonpyrogenic. Distributed by AuroMedics Pharma LLC and made in India. The packaging contains 10 vials of 20 mg each. The label also features the Novaplus logo and various warnings about usage and storage.*

FDA Label Image

Vecuronium-figure-5 (Vecuronium Fig5)

Vecuronium Bromide for Injection label panel in red and black text. The label includes blank fields for medication concentration (mg/mL), date mixed, time mixed, prepared by, lot number, and expiration date. The lot code P1429271 is printed vertically on the right side.*

FDA Label Image

Vecuronium Bromide Chemcal Structure (Vecuronium Str)

Chemical structure of Vecuronium Bromide showing its steroidal framework with quaternary ammonium groups and bromide counterion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.